Best Work Places

WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025

WuXi XDC Cayman Inc. a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC's leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing. Industry-leading development and manufacturing capabilities (Best ADC CDMO in Asia & China): WuXi XDC's state-of-the-art facilities and global dual-sourcing strategy enable seamless CMC development and GMP manufacturing, accelerating the timeline while ensuring a high success rate and regulatory excellence. Innovation in Discovery & Development (Best ADC CRO in Asia): WuXi XDC's proprietary conjugation and payload-linker technologies, along with the incorporation of external technologies through partnerships, drive ADC and XDC discovery, optimization, and IND-enabling studies, expediting clients' clinical advancement. Pioneering ADC Technology (Best ADC Platform Technology): Through next-generation payload-linker innovations and site-specific conjugation technologies, from internal development and external partnership, WuXi XDC provides clients with diversified technology suites to advance ADC and XDC developments. Dr. Jimmy Li, CEO of WuXi XDC, commented: "We are honored to receive these prestigious awards, which not only reaffirm our team's relentless pursuit of excellence and innovation in the ADC field but also underscore our dedication to delivering world-class services that empower our clients to bring novel therapies to patients worldwide. They are a testament to the hard work and dedication of every WuXi XDC employee – their relentless efforts that have made this milestone possible. It also belongs to our valued partners, whose trust and collaboration have driven our collective success. Looking ahead, WuXi XDC will continue to support our clients and advance the innovation and progress of the global bioconjugate industry." These awards follow WuXi XDC's recent recognition at the 2024 World ADC Awards, where the company was named Best CDMO Winner for the second consecutive year, further solidifying its leadership position in the global ADC industry. As the ADC market continues to experience sustainable growth, WuXi XDC relentlessly committed to advancing its technological capabilities and expanding its service offerings to meet clients' evolving needs.

Exact Sciences Wins 2025 Gallup Exceptional Workplace Award

Exact Sciences Corp, announced it has received the 2025 Gallup Exceptional Workplace Award (GEWA), marking the second year in a row the company has received this prestigious recognition. This award recognizes the most engaged workplace cultures in the world. Gallup created the Exceptional Workplace Award to identify excellence and celebrate organizations that incorporate employee engagement into the bedrock of how they do their work, motivate their teams, and achieve business outcomes. "Exact Sciences’ success starts with our people, and winning the Gallup Exceptional Workplace Award for the second consecutive year is a testament to the dedication of our incredible team," said Sarah Condella, executive vice president of human resources at Exact Sciences. "Our culture is built on shared values, collaboration, and a relentless commitment to our mission. By fostering an environment where employees feel engaged, supported, and empowered, we continue to make a meaningful impact on patients and advance our fight against cancer." “Congratulations to this year’s Gallup Exceptional Workplace Award winners for setting the standard for a thriving workplace. Your commitment to creating an environment where employees feel valued, heard and empowered to do their best work is truly remarkable. By prioritizing both people and performance, you are shaping the future of work and proving that exceptional workplaces drive real results,” said Jon Clifton, Gallup’s chief executive officer. Gallup’s meta-analysis on team engagement and performance is the most comprehensive workplace study ever conducted, with data on more than 3.3 million employees in 347 organizations across 53 industries and 90 countries. The company’s research shows that highly engaged organizations significantly outperform their peers in important business outcomes, including customer ratings, profitability, productivity, turnover, safety incidents, shrinkage, absenteeism, quality, well-being, and organizational citizenship. Exact Sciences is looking for talented people who are passionate about helping patients and fighting cancer

Advantum Health Recognized as one of Kentucky's Best Places to Work for Second Consecutive Year

Advantum Health, an industry-leading practice revenue management authority based in Louisville, has been recognized by The Kentucky Chamber of Commerce and the Kentucky Society for Human Resource Management (KYSHRM) as one of 2025's Best Places to Work in Kentucky. Tammy Taylor, CEO of Advantum Health, shared her excitement, "Our culture at Advantum Health attracts talent to the company and helps retain good team members over time. We have fostered an inclusive and open culture that allows employees to express themselves and be heard. Our clients reap the benefits of this dedicated, talented and high-performing workforce. And consistent communication has worked wonders in keeping our team members engaged." Managed by Workforce Research Group, the selection process is based on the results of an internal employee survey as well as a thorough assessment of the company's benefits, perks, employee policies and procedures. Advantum is dedicated to employee support and engagement through programs such as: Town hall meetings to give "state of the company" addresses, Multiple mentorship groups at different levels of the company, Go Green Committee to advance sustainability and volunteerism, Dedicated training and education team, Veterans support group, Buddy program to pair new employees with existing team members. Chief Administrative Officer, Samantha Wagner, discussed Advantum's unique culture, saying, "In a partially remote and global work environment, technology and team building are necessary to facilitate authentic relationships and healthy collaboration. Our leadership team is passionate about the work we do and the benefits we deliver to clients, and that commitment is demonstrated on a daily basis through strategic vision, open door policies, and a high level of interaction with team members across the company. From improved PTO policies, to mentorship, to elective volunteerism and even healthy snacks and a workout facility at headquarters, we are making this a place people want to be."

AGC Biologics Wins CDMO Leadership Awards

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the company won two awards from the annual CDMO Leadership awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough to be honored in multiple categories. The awards are decided through survey-based scoring and focus on a set of performance metrics across important areas such as facilities, innovation, scientific expertise, on-time delivery, seamless delivery across phases, manufacturing capabilities, and quality management systems. The program independently surveys leading global biopharma and biotechnology organizations to tabulate scores and uses feedback from only experienced industry leaders to decide the best CDMOs in the world. “We are honored that our customers and industry leaders have confidence in our global CDMO services for biologics and cell and gene therapies,” said Alberto Santagostino, CEO and President, AGC Biologics. “AGC Biologics remains committed to offering friendly and expert CDMO services and being a collaborative partner. This is what we stand for. We aim to be a safe harbor for our Biopharma companies to help bring life-changing treatments to patients around the globe.” “We are thrilled to introduce our 2025 CDMO Leadership Awards winners to the Outsourcing community, and honored to offer such an important tool for drug sponsors in selecting their best-fit partner to help bring life-saving therapies to market,” says Outsourced Pharma Chief Editor Louis Garguilo. “The new categories and enhanced scoring methodology that went into this year’s appraisal bring an improved experience for drug sponsors using the resource as well as an ever-so-coveted distinction for the CDMOs. The unveiling of the award champions during our celebration in March will be an exciting new addition to the festivities.”

Sun Pharma Included in S&P Global Sustainability Yearbook 2025

Sun Pharmaceutical Industries Limited announced that it has been included in the S&P Global Sustainability Yearbook 2025. Sun Pharma has qualified in the Top 5% of pharmaceutical companies assessed by S&P globally for this Yearbook. Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability. This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. Dilip Shanghvi, Chairman & Managing Director of the Company said, “We continue to focus on delivering sustainable outcomes for all our stakeholders. Sustainability is an integral part of our way of doing business and we remain steadfast in our commitment to align our strategy with universal ESG principles and to undertake the requisite steps for further advancing societal goals.”

Rockwell Medical Named 'Great Place to Work'

Rockwell Medical, a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company has been certified as a Great Place to Work® for the third year in a row. "We have built a high-trust culture here are Rockwell Medical with team members who are invested in the success of our organization," said Lesley Spriggs, Vice President of Human Resources at Rockwell Medical. "Being named a 'Great Place to Work' for the third year in a row reflects the tremendous progress that we have made over the past several years fostering a workplace that supports innovation, sustainable performance and business agility. The 'Great Place to Work' accreditation directly reflects how our employees feel about their experience working at Rockwell Medical, highlighting attributes such as credibility, respect, fairness, pride and camaraderie, to name a few. Additionally, our employees recognize that their work has special meaning especially taking into account that patients are positively impacted by the hemodialysis products we manufacture every day. We are grateful for the constructive feedback that we receive through this accreditation process and look forward to further enhancing the benefits and qualities of working at Rockwell."

Kipu Health Recognized in 2025 South Florida Business Journal "Best Places to Work" List

Kipu Health, the leading provider of technology solutions for behavioral health, today announced its selection as a Best Places to Work honoree by the South Florida Business Journal. "Being named a Best Place to Work is a tremendous honor," said Carina Edwards, CEO of Kipu Health. "This achievement is a testament to our team's dedication to our core values, our culture of continuous improvement, and our unwavering commitment to our clients. We strive to create an environment where every team member can grow and thrive." Kipu's dedication to its growing employee base focuses on company values, investing in growth and development, and delivering perks that go beyond standard offerings. The company also strives to provide a nurturing a culture that drives business success. "This award reaffirms our belief in the power of teamwork," said Edwards. "As a Kipu family, we're driven by a shared passion to value every individual and deliver outstanding service to our clients."

WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year

WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been awarded a Platinum Medal by the EcoVadis Sustainability Rating, marking the second year the company has received the rating's highest level of recognition. EcoVadis is a leading sustainability intelligence platform for global supply chains. Its sustainability ratings cover seven management indicators, across 21 sustainability criteria, under four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. The performance of companies is evaluated by assessing their policies, actions and results, and weighing inputs that come from third-party professionals and external stakeholders. In the newly published ratings scorecard, WuXi Biologics was ranked in the top 1% of more than 150,000 companies evaluated worldwide. Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are very pleased to be once again recognized by EcoVadis with the Platinum Medal, which reflects our success in enhancing our sustainability capabilities. As a global leader in Green CRDMO, we are committed to continuously delivering ESG excellence, enabling partners worldwide to fulfill ESG goals, and jointly working with all stakeholders to promote responsible practices throughout the entire value chain." As a participant in the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively contributes to advocating sustainability, and has earned widespread recognition for its efforts. It was included in the UNGC 20 Case Examples of Sustainable Development for 20 Years Collection for its world-leading green biologics solutions; granted an MSCI AAA Rating and included in Dow Jones Sustainability Indices for two consecutive years; recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; named to the CDP Water Security "A list" and awarded an "A-" CDP Climate Change score; selected as a Constituent of the FTSE4Good Index Series; and listed in the Hang Seng ESG 50 Index.

TraceLink Named a Top 10 Pharma and Life Sciences Technology Solution Provider by CIOTechOutlook

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOTechOutlook as one of the Top 10 Pharma and Life Sciences Technology Solution Providers. This accolade highlights TraceLink's significant role in driving the digital transformation of pharmaceutical supply chains and enhancing patient safety worldwide. With OPUS, the Orchestration Platform for Universal Solutions, TraceLink is redefining how Life Sciences and Healthcare companies approach end-to-end supply chain digitalization. Supply chains face challenges like inaccurate forecasting, poor inventory management, delayed deliveries, and limited visibility, worsened by fragmented systems, compliance demands, and evolving commerce. As the only no-code network digitalization platform designed to democratize access to end-to-end supply chain integration and orchestration, OPUS empowers supply chain leaders to achieve radical business benefits such as lower out-of-stock, freeing up working capital, and improved operational efficiency. "This recognition reflects the progress we're making in transforming supply chains into dynamic, patient-focused ecosystems," said Shabbir Dahod, President and CEO of TraceLink. "For CIOs, our platform is a game-changer, simplifying the complexities of global supply chains by enhancing compliance, collaboration, and operational efficiency. Real-time data fuels AI/ML models, and by enabling companies to create clean, real-time data sets, we empower them to innovate, protect patient well-being, and achieve impactful business results." CIOTechOutlook recently sat down with CEO Shabbir Dahod to gain insights from his two-decade career and hear his perspectives on the future of global supply chains. In the interview, Dahod shares his vision for how advancements in digital networks, predictive analytics, and AI-powered orchestration are set to revolutionize the industry, enabling unprecedented levels of collaboration and transparency. "TraceLink's solutions are empowering given the complex nature of global pharmaceutical supply chains," said Sudhakar Singh, Editor, CIOTechOutlook. "Its solutions ensure a smooth collaboration between the stakeholders like manufacturers, distributors, and healthcare providers. The connectivity makes it easier to conduct business more coherently even as the supply chain challenges evolve."